Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-16

FDA Approved: IMIPRAMINE PAMOATE — Original Application (Hikma Pharmaceuticals USA Inc)

View source ↗

Summary

FDA approves the original application for Imipramine Pamoate (generic) from Hikma Pharmaceuticals USA Inc. for use in treating depression and nocturnal enuresis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine Pamoate (Imipramine pamoate)

Snippet

ORIG AP for IMIPRAMINE PAMOATE (IMIPRAMINE PAMOATE)